Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, today reaffirmed the strength of its fish-skin platform following the December 24, ...

(RTTNews) - Medical products and technologies company Convatec Group Plc (CTEC.L, CNVVY) Monday announced that it has raised its sales outlook of InnovaMatrix for fiscal 2025, after the U.S. Centers ...

Organogenesis (ORGO) and MiMedx (MDXG) traded lower on Friday after the Centers for Medicare & Medicaid Services (CMS) announced the withdrawal of final Local Coverage Determinations (LCDs) related to ...

Coverage for the majority of BioStem’s non-acute revenue, treatment for pressure ulcers, also remains unaffected by CMS LCD updates Under the final policy, CMS and the Medicare Administrative ...

Investing.com -- Celularity Inc (NASDAQ:CELU) stock dropped 2.8% in premarket trading Friday after the Centers for Medicare & Medicaid Services (CMS) withdrew Local Coverage Determinations (LCDs) for ...

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert J. Hariri welcomed the recent action taken under ...

MENLO PARK, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative technology ...

Management reiterated confidence that the next step is the publication of a draft local coverage determination (LCD) for EsoGuard, following the CAC meeting. Aklog stated, "we are very confident that ...

Legacy LCDs across MACs such as CGS, Novitas, and FCSO continue unchanged. Palmetto, NGS, WPS, and Noridian remain without an active LCD. The previously announced $127/cm² fixed payment rate will ...

ARLINGTON, Va. & REYKJAVIK, Iceland, December 26, 2025--(BUSINESS WIRE)--Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, today ...